New classification of antirheumatic drugs. The evolution of a concept

The effect of hydroxychloroquine on activities of daily living and hand function in systemic sclerosis: results from an analysis of the EUSTAR cohort.

Arthritis research & therapy·2025

The American English version of the validated French Flare Assessment in RA Questionnaire (FLARE-RA).

Clinical rheumatology·2019

Defining Skin Ulcers in Systemic Sclerosis: Systematic Literature Review and Proposed World Scleroderma Foundation (WSF) definition.

Journal of scleroderma and related disorders·2018

Remodeling of the HDL proteome with treatment response to abatacept or adalimumab in the AMPLE trial of patients with rheumatoid arthritis.

Atherosclerosis·2018

Secular trends in the impact factors of SLE publications over a 45-year period-a systematic review.

Lupus·2018

There is a need for new systemic sclerosis subset criteria. A content analytic approach.

Scandinavian journal of rheumatology·2017

Rethinking Anti-CD20 Therapies: From Fixed to Precision Dosing.

The Journal of rheumatology·2026

Longitudinal comparison of treat-to-target states and clinical outcomes in patients with late-onset versus early-onset systemic lupus erythematosus.

The Journal of rheumatology·2026

Remission rates of patients with axial spondyloarthritis in a tertiary care center.

The Journal of rheumatology·2026

Uncovering heterogeneous health burden in axial spondyloarthritis through latent class analysis of the ASAS health index.

The Journal of rheumatology·2026

Mendelian randomisation for rheumatology: beyond hype-what it's good for, what it can't do, and how to read it critically.

The Journal of rheumatology·2026

Juvenile Arthritis Quality of Life Questionnaire Responder Metrics in Juvenile Idiopathic Arthritis: Clarifying Health-Related Quality of Life Changes Across Treatment Eras.

The Journal of rheumatology·2026

Implementation of the In Vitro Seizure Liability Assay (iLAseizure) in Drug Discovery and Development: Mechanism of Action Case Studies.

Pharmacology research & perspectives·2026

In Silico Evaluation of Annonaceous Acetogenins as Potential HER2 and MELK Inhibitors for Targeted Cancer Therapy.

Anti-cancer agents in medicinal chemistry·2026

Computational Discovery of Phytochemicals Targeting InhA of Mycobacterium tuberculosis: Insights from Molecular Docking, MMGBSA, ADME Profiling, and Molecular Dynamics Simulations.

Current computer-aided drug design·2026

Chalcones as a Platform for the Development of Novel Antiviral Agents: A Review.

Mini reviews in medicinal chemistry·2026

Design of Quinazoline Dual Inhibitors Targeting Focal Adhesion Kinase and Polo-like Kinase 1 for Metastatic Cancers: QSAR, Pharmacophore Modelling, and Molecular Docking Approaches.

Current pharmaceutical design·2026

In-silico Identification of Cyclic Peptide Inhibitors for A42r Profilin-like Protein from Monkeypox Virus.

Current drug targets·2026

Related Experiment Videos

New classification of antirheumatic drugs. The evolution of a concept

Related Concept Videos

The effect of hydroxychloroquine on activities of daily living and hand function in systemic sclerosis: results from an analysis of the EUSTAR cohort.

The American English version of the validated French Flare Assessment in RA Questionnaire (FLARE-RA).

Defining Skin Ulcers in Systemic Sclerosis: Systematic Literature Review and Proposed World Scleroderma Foundation (WSF) definition.

Remodeling of the HDL proteome with treatment response to abatacept or adalimumab in the AMPLE trial of patients with rheumatoid arthritis.

Secular trends in the impact factors of SLE publications over a 45-year period-a systematic review.

There is a need for new systemic sclerosis subset criteria. A content analytic approach.

Rethinking Anti-CD20 Therapies: From Fixed to Precision Dosing.

Longitudinal comparison of treat-to-target states and clinical outcomes in patients with late-onset versus early-onset systemic lupus erythematosus.

Remission rates of patients with axial spondyloarthritis in a tertiary care center.

Uncovering heterogeneous health burden in axial spondyloarthritis through latent class analysis of the ASAS health index.

Mendelian randomisation for rheumatology: beyond hype-what it's good for, what it can't do, and how to read it critically.

Juvenile Arthritis Quality of Life Questionnaire Responder Metrics in Juvenile Idiopathic Arthritis: Clarifying Health-Related Quality of Life Changes Across Treatment Eras.

Implementation of the In Vitro Seizure Liability Assay (iLAseizure) in Drug Discovery and Development: Mechanism of Action Case Studies.

In Silico Evaluation of Annonaceous Acetogenins as Potential HER2 and MELK Inhibitors for Targeted Cancer Therapy.

Computational Discovery of Phytochemicals Targeting InhA of Mycobacterium tuberculosis: Insights from Molecular Docking, MMGBSA, ADME Profiling, and Molecular Dynamics Simulations.

Chalcones as a Platform for the Development of Novel Antiviral Agents: A Review.

Design of Quinazoline Dual Inhibitors Targeting Focal Adhesion Kinase and Polo-like Kinase 1 for Metastatic Cancers: QSAR, Pharmacophore Modelling, and Molecular Docking Approaches.

In-silico Identification of Cyclic Peptide Inhibitors for A42r Profilin-like Protein from Monkeypox Virus.

Related Experiment Videos

New classification of antirheumatic drugs. The evolution of a concept

Related Concept Videos

Related Articles